vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and GRIFFON CORP (GFF). Click either name above to swap in a different company.

GRIFFON CORP is the larger business by last-quarter revenue ($649.1M vs $487.7M, roughly 1.3× CLOVER HEALTH INVESTMENTS, CORP.). GRIFFON CORP runs the higher net margin — 9.9% vs -10.1%, a 20.0% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 2.6%). GRIFFON CORP produced more free cash flow last quarter ($99.3M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs -1.8%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Griffon Corporation is a multinational conglomerate headquartered in New York City. It operates as a diversified management and holding company. The company has four subsidiaries: Ames True Temper, ClosetMaid, Clopay Building Products, and CornellCookson. Griffon has been publicly traded since 1961 and is listed on the New York Stock Exchange as a component stock of the S&P SmallCap 600, S&P Composite 1500, and Russell 2000 indices.

CLOV vs GFF — Head-to-Head

Bigger by revenue
GFF
GFF
1.3× larger
GFF
$649.1M
$487.7M
CLOV
Growing faster (revenue YoY)
CLOV
CLOV
+42.1% gap
CLOV
44.7%
2.6%
GFF
Higher net margin
GFF
GFF
20.0% more per $
GFF
9.9%
-10.1%
CLOV
More free cash flow
GFF
GFF
$168.3M more FCF
GFF
$99.3M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
-1.8%
GFF

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
CLOV
CLOV
GFF
GFF
Revenue
$487.7M
$649.1M
Net Profit
$-49.3M
$64.4M
Gross Margin
41.1%
Operating Margin
-10.1%
17.5%
Net Margin
-10.1%
9.9%
Revenue YoY
44.7%
2.6%
Net Profit YoY
-123.2%
-9.1%
EPS (diluted)
$1.41

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GFF
GFF
Q4 25
$487.7M
$649.1M
Q3 25
$496.6M
$662.2M
Q2 25
$477.6M
$613.6M
Q1 25
$462.3M
$611.7M
Q4 24
$337.0M
$632.4M
Q3 24
$331.0M
$659.7M
Q2 24
$356.3M
$647.8M
Q1 24
$346.9M
$672.9M
Net Profit
CLOV
CLOV
GFF
GFF
Q4 25
$-49.3M
$64.4M
Q3 25
$-24.4M
$43.6M
Q2 25
$-10.6M
$-120.1M
Q1 25
$-1.3M
$56.8M
Q4 24
$-22.1M
$70.9M
Q3 24
$-9.2M
$62.5M
Q2 24
$7.4M
$41.1M
Q1 24
$-19.2M
$64.1M
Gross Margin
CLOV
CLOV
GFF
GFF
Q4 25
41.1%
Q3 25
41.7%
Q2 25
43.2%
Q1 25
41.2%
Q4 24
41.8%
Q3 24
24.5%
39.9%
Q2 24
30.3%
38.5%
Q1 24
23.6%
40.2%
Operating Margin
CLOV
CLOV
GFF
GFF
Q4 25
-10.1%
17.5%
Q3 25
-4.9%
18.0%
Q2 25
-2.2%
-20.5%
Q1 25
-0.3%
16.5%
Q4 24
-6.4%
17.7%
Q3 24
-2.7%
16.9%
Q2 24
2.0%
13.8%
Q1 24
-6.5%
16.9%
Net Margin
CLOV
CLOV
GFF
GFF
Q4 25
-10.1%
9.9%
Q3 25
-4.9%
6.6%
Q2 25
-2.2%
-19.6%
Q1 25
-0.3%
9.3%
Q4 24
-6.6%
11.2%
Q3 24
-2.8%
9.5%
Q2 24
2.1%
6.3%
Q1 24
-5.5%
9.5%
EPS (diluted)
CLOV
CLOV
GFF
GFF
Q4 25
$1.41
Q3 25
$1.04
Q2 25
$-2.65
Q1 25
$1.21
Q4 24
$1.49
Q3 24
$1.29
Q2 24
$0.84
Q1 24
$1.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GFF
GFF
Cash + ST InvestmentsLiquidity on hand
$78.3M
$95.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$108.9M
Total Assets
$541.0M
$2.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GFF
GFF
Q4 25
$78.3M
$95.3M
Q3 25
$99.0M
Q2 25
$107.3M
Q1 25
$127.8M
Q4 24
$194.5M
$152.0M
Q3 24
$288.0M
$114.4M
Q2 24
$254.8M
$133.5M
Q1 24
$208.3M
$123.0M
Total Debt
CLOV
CLOV
GFF
GFF
Q4 25
Q3 25
Q2 25
$1.5B
Q1 25
$1.5B
Q4 24
$1.5B
Q3 24
$1.5B
Q2 24
$1.5B
Q1 24
$1.6B
Stockholders' Equity
CLOV
CLOV
GFF
GFF
Q4 25
$308.7M
$108.9M
Q3 25
$340.9M
$74.0M
Q2 25
$344.2M
$63.9M
Q1 25
$336.1M
$214.7M
Q4 24
$341.1M
$227.8M
Q3 24
$342.2M
$224.9M
Q2 24
$324.9M
$223.5M
Q1 24
$292.5M
$202.2M
Total Assets
CLOV
CLOV
GFF
GFF
Q4 25
$541.0M
$2.1B
Q3 25
$559.7M
$2.1B
Q2 25
$575.0M
$2.1B
Q1 25
$583.7M
$2.3B
Q4 24
$580.7M
$2.3B
Q3 24
$653.0M
$2.4B
Q2 24
$674.2M
$2.4B
Q1 24
$671.8M
$2.4B
Debt / Equity
CLOV
CLOV
GFF
GFF
Q4 25
Q3 25
Q2 25
22.71×
Q1 25
7.16×
Q4 24
6.48×
Q3 24
6.78×
Q2 24
6.74×
Q1 24
7.84×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GFF
GFF
Operating Cash FlowLast quarter
$-66.9M
$107.0M
Free Cash FlowOCF − Capex
$-69.0M
$99.3M
FCF MarginFCF / Revenue
-14.1%
15.3%
Capex IntensityCapex / Revenue
0.4%
1.2%
Cash ConversionOCF / Net Profit
1.66×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$278.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GFF
GFF
Q4 25
$-66.9M
$107.0M
Q3 25
$12.1M
$75.0M
Q2 25
$5.4M
$123.1M
Q1 25
$-16.3M
$16.5M
Q4 24
$34.8M
$142.9M
Q3 24
$50.0M
$72.1M
Q2 24
$44.8M
$122.1M
Q1 24
$25.9M
$39.8M
Free Cash Flow
CLOV
CLOV
GFF
GFF
Q4 25
$-69.0M
$99.3M
Q3 25
$11.4M
$62.4M
Q2 25
$4.8M
$114.4M
Q1 25
$-16.5M
$2.8M
Q4 24
$33.3M
$125.5M
Q3 24
$49.6M
$51.6M
Q2 24
$44.4M
$107.5M
Q1 24
$25.5M
$20.8M
FCF Margin
CLOV
CLOV
GFF
GFF
Q4 25
-14.1%
15.3%
Q3 25
2.3%
9.4%
Q2 25
1.0%
18.6%
Q1 25
-3.6%
0.5%
Q4 24
9.9%
19.8%
Q3 24
15.0%
7.8%
Q2 24
12.5%
16.6%
Q1 24
7.3%
3.1%
Capex Intensity
CLOV
CLOV
GFF
GFF
Q4 25
0.4%
1.2%
Q3 25
0.1%
1.9%
Q2 25
0.1%
1.4%
Q1 25
0.0%
2.2%
Q4 24
0.5%
2.8%
Q3 24
0.1%
3.1%
Q2 24
0.1%
2.2%
Q1 24
0.1%
2.8%
Cash Conversion
CLOV
CLOV
GFF
GFF
Q4 25
1.66×
Q3 25
1.72×
Q2 25
Q1 25
0.29×
Q4 24
2.02×
Q3 24
1.15×
Q2 24
6.04×
2.97×
Q1 24
0.62×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLOV
CLOV

Segment breakdown not available.

GFF
GFF

Consumer And Professional Products$241.1M37%
Residential Repairand Remodel$202.1M31%
International Excluding North America$97.8M15%
Retail$47.3M7%
Residential New Construction$32.5M5%
Other$14.2M2%
Industrial$14.1M2%

Related Comparisons